We are recruiting laboratories to assess and support the establishment of the first WHO International Standard for anti-Rift Valley fever virus antibodies. The study is supported by CEPI.

Join our collaborative study: ow.ly/R2Gi50IkCno

#RiftValleyFever #WHO

We are pleased to introduce new standards for SARS-CoV-2, influenza and other quality control reagents.

See our catalogue at nibsc.org/latest_standar…

Our leading scientist, Dr Haiyan Jia, has recently published a paper on our first WHO International Standard for Harmonizing the Biological Activity of Bevacizumab

Read more: nibsc.org/about_us/lates…

Chrysi Sergaki, Interim Head of the Microbiome Section will be talking about tackling antimicrobial resistance in the UK and the UK’s role on the global stage at the Westminster Health Forum today. Find out more westminsterforumprojects.co.uk/conference/Ant…

Our interim Head of the Microbiome Section is presenting on developing global standards for the microbiome field at BioTech Pharma Summit today. Join her biotechpharmasummit.com/index.php/prob…

Making a payment to NIBSC? Use our new free payment service #NIBSCPay today.

ow.ly/1J6T50GQUgT

Our scientists have played a leading role in the development of a the novel oral polio vaccine type 2 (nOPV2). This essential tool in the fight against vaccine-derived poliovirus type 2 (cVDPV2) has recently been recommended for wider use.

Read more: ow.ly/Ryno50GEZZE

We are recruiting laboratories to assess and to support the establishment of the proposed first WHO International Standards for EGFR variants

Join our collaborative study: nibsc.org/science_and_re…
#cancer #biomarkers #diagnostics #standardisation #WHO

Introducing our latest standards, now available through our website. View the catalogue at nibsc.org/products/lates…

Dr Chrysi Sergaki has published on ‘Exploring how microbiome signatures change across inflammatory bowel disease conditions and disease locations’.

Read the article here🔎 ow.ly/wDkj50GisyX

In a recent study, NIBSC scientists utilised proteomics to help understand why some individuals survived and others not during an outbreak of meningococcal disease and the impact licensed vaccines would have on patient outcomes.
Read more nibsc.org/about_us/lates…

We are pleased to announce that NIBSC will work with Cell and Gene Therapy Catapult to explore a new standard for the AAV virus to help harmonise gene therapies.

This is made possible by a grant from the £3.7 million Regulators' Pioneer Fund launched by the @beisgovuk

ow.ly/gLDd50Gbg1y

Developing a new #vaccine typically takes more than a decade. The NIBSC participates in #Inno4Vac , a new European partnership to innovate vaccine development. Find out more: bit.ly/2UAMqJW #IMICarryTheTorch @europevaccine

Dr Nicola Rose, Head of Virology at the MHRA's National Institute for Biological Standards and Control, talked to EMJ Reviews about her work on Ebola, SARS-CoV-2 and most recently COVID-19.

Read the interview: ow.ly/oc4F50FUReP

Our development of the MAT supports the safe testing of novel vaccines to overcome infections such as Shigella and iNTS. Read more: ncbi.nlm.nih.gov/pmc/articles/P…

Join our expert, Chrysi Sergaki at the ‘Investigating the Ocular Surface Microbiome’ meeting on the 2 August and learn more on best practices for low-biomass microbial research.

Register for the symposium (ow.ly/29wJ50FEAg4)

NIBSC Scientist, Anthony R. Hubbard has recently been awarded the Harold R. Roberts medal by The International Society on Thrombosis and Haemostasis for his significant contributions to the Scientific and Standardization Committee (SSC).

Read more here: isth.org/news/573809/IS…

Join our expert, Chrysi Sergaki Chrysi Sergaki at the ‘Investigating the Ocular Surface Microbiome’ meeting on the 2 August and learn more on best practices for low-biomass microbial research.

Register for the symposium (ow.ly/ciJ250FEzQF)

The NIBSC is working to support the design and establishment of a sustainable European vaccine research infrastructure as part of TRANSVAC-DS. Find out more nibsc.org/about_us/lates…

Our scientist, Dr Paul Matejtschuk, will be presenting on ‘Vial Impedance Spectroscopy and its application in the freeze drying of biologicals’ at a virtual conference at the end of this month.

View the programme here: qepler.com/agendas/3rd-ph…